$2.09
-0.21-8.93%
At close: -
$2.10
0.010.48%
After Hours: 7:26 PM EDT
Outlook Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Outlook Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2024-12-27 | $-0.94 | $-0.85 | -10.6 % |
Q3 | 2024-08-14 | $-0.83 | $-1.01 | 17.8 % |
Q2 | 2024-05-15 | $-1.55 | $-0.85 | -82.3 % |
Q3 | 2023-08-14 | $-1.60 | $-1.00 | -60.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2021-12-22 | $0 | $300.00K | -100.0 % |
Q3 | 2021-08-13 | $0 | $320.00K | -100.0 % |
Q2 | 2021-05-14 | $0 | $320.00K | -100.0 % |
Outlook Therapeutics (OTLK) is scheduled to report earnings on February 12, 2025. The last reported earnings were for reported on December 27, 2024 for Q4.
The Actual EPS was $-0.94, which missed the estimate of $-0.85.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.